We are live on ! Find out more
RMSCM

R.M. Sincerbeaux Capital Management Portfolio holdings

AUM $188M
1-Year Est. Return 12.59%
This Fund
S&P 500
This Quarter Est. Return
+6.86%
1 Year Est. Return
+12.59%
3 Year Est. Return
+76.42%
5 Year Est. Return
+87.03%
10 Year Est. Return
+380.68%
AUM
$106M
AUM Growth
+$3.05M
Cap. Flow
-$2.11M
Cap. Flow %
-2%
Top 10 Hldgs %
49.68%
Holding
55
New
1
Increased
3
Reduced
10
Closed
2

Top Buys

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$2.17M
2
CCI icon
Crown Castle
CCI
+$123K
3
ABBV icon
AbbVie
ABBV
+$54.9K
4
WMB icon
Williams Companies
WMB
+$24.1K

Sector Composition

Rank Sector Weight
1 Technology 24.72%
2 Financials 22.05%
3 Energy 15.8%
4 Healthcare 9.91%
5 Industrials 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ITW icon
51
Illinois Tool Works
ITW
$82.9B
$269K 0.25%
2,198
VZ icon
52
Verizon
VZ
$195B
$254K 0.24%
4,752
PEP icon
53
PepsiCo
PEP
$187B
$209K 0.2%
2,000
-86
-4% -$9.01K
PSX icon
54
Phillips 66
PSX
$89.2B
-2,600
Closed -$209K
TEVA icon
55
Teva Pharmaceuticals
TEVA
$43.3B
-19,560
Closed -$900K

Similar funds

R.M. Sincerbeaux Capital Management's Q4 2016 Portfolio in Review

As of Q4 2016, R.M. Sincerbeaux Capital Management held 55 positions worth $106M, up 3% from $103M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

R.M. Sincerbeaux Capital Management's Q4 2016 filing shows 1 new, 3 increased, 10 reduced and 2 closed positions. Its largest new stake was Viatris: 58,300 shares worth $2.22M. The largest sale was Kinder Morgan, an estimated $1.64M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Energy.

  • R.M. Sincerbeaux Capital Management's largest Q4 2016 buy was Viatris: 58,300 shares worth $2.22M.
  • R.M. Sincerbeaux Capital Management added most to Crown Castle in Q4 2016, an estimated $123K increase.
  • R.M. Sincerbeaux Capital Management's biggest Q4 2016 reduction was Kinder Morgan, cutting an estimated $1.64M.
  • R.M. Sincerbeaux Capital Management fully exited Teva Pharmaceuticals in Q4 2016, selling an estimated $900K.
  • R.M. Sincerbeaux Capital Management's ten largest holdings make up 50% of its $106M portfolio in Q4 2016.
  • R.M. Sincerbeaux Capital Management opened 1 new position and closed 2 in Q4 2016.
  • R.M. Sincerbeaux Capital Management's portfolio value rose 3% quarter-over-quarter to $106M.

Based on R.M. Sincerbeaux Capital Management's 13F filing for Q4 2016, filed 13 Feb 2017.